Pediatrix Medical Group, Inc.
MDNYSEHealthcare● Active
$22.61
+$0.24(+1.07%)
Market Cap$1.9B
P/E Ratio—
52W High$24.99
52W Low$11.84
Pediatrix Medical Group, Inc. (MD) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MD · as of 2026-06-08
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | ($0.10B) | ($0.06B) | $0.06B | $0.11B |
| Depreciation & Amort. | $0.00B | $0.03B | $0.04B | $0.04B | $0.03B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.01B | $0.02B | $0.02B |
| Change in Working Capital | $0.04B | $0.09B | ($0.01B) | $0.03B | ($0.02B) |
| Net Cash from Operations | $0.27B | $0.21B | $0.14B | $0.17B | $0.08B |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.02B) | ($0.03B) | ($0.03B) | ($0.03B) |
| Purchases of Investments | $0.00B | ($0.06B) | ($0.03B) | ($0.02B) | ($0.04B) |
| Sales of Investments | $0.00B | $0.05B | $0.02B | $0.02B | $0.02B |
| Net Cash from Investing | ($0.02B) | ($0.04B) | ($0.05B) | ($0.06B) | ($0.05B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.09B) | ($0.00B) | ($0.00B) | ($0.09B) | ($0.00B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.02B) | ($0.02B) | ($0.02B) | ($0.41B) | ($0.76B) |
| Net Cash from Financing | ($0.11B) | ($0.01B) | ($0.03B) | ($0.49B) | ($0.76B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.25B | $0.18B | $0.10B | $0.14B | $0.04B |
| FCF Margin %(computed) | 13.20% | 9.17% | 5.21% | 6.96% | 2.33% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Pediatrix Medical Group, Inc. data
About Pediatrix Medical Group, Inc. (MD) Cash Flow Statement
Pediatrix Medical Group, Inc. generated operating cash flow of $0.27B and free cash flow of $0.25B for 2025 — a FCF margin of 13.20%. Capital expenditure was ($0.02B).
Frequently asked questions
MD · 4 questionsPediatrix Medical Group, Inc. generated free cash flow of $0.25B for 2025, up 36.9% year-over-year.
MD free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08